Skip to content

The Critical Care Response to the COVID-19 Pandemic in Madrid

The Critical Care Resources Adaptation to the SARS-CoV-2 Pandemic in Madrid

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04393324
Acronym
Tetrix
Enrollment
2500
Registered
2020-05-19
Start date
2020-04-24
Completion date
2020-06-30
Last updated
2020-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Human, COVID-19

Keywords

COVID-19, ARDS, Relocation, ICU capacity

Brief summary

Description of the adaptation of ICUs in the region of Madrid to que surge in demand of critical care due to COVID-19

Detailed description

Background The worldwide SARS-CoV-2 pandemic has put healthcare systems under the extreme pressure, with intensive care units being faced with a previously unseen number of patients with severe respiratory failure requiring admission for endotracheal intubation and mechanical ventilation. Methods The study describes how the critical care resources adapted to the sudden surge of severe Covid-19 in the province of Madrid, which developed at the beginning of March 2020. The response consisted of a swift increase in ICU capacity and the relocation of patients. ICU beds were mounted outside the usual intensive care areas. Transfer of critically ill intubated patients with COVID-19 was managed in an instant messenger service group composed of representatives of 53 intensive care units and performed by the Madrid Emergency Medical Systems (EMS). The investigators will compare transferred with non-transferred patients matched for risk factors for cardiovascular and respiratory complications.

Interventions

None listed

Sponsors

FUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO SAN CARLOS
CollaboratorOTHER
Hospital San Carlos, Madrid
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Admitted to ICU in Madrid with COVID-19

Exclusion criteria

* Admitted to ICU without COVID-19

Design outcomes

Primary

MeasureTime frameDescription
Mortality9 weeksICU mortality

Secondary

MeasureTime frameDescription
Length of ICU stay9 weeksFrom admission to discharge or death

Countries

Spain

Contacts

Primary ContactMiguel S Sanchez Garcia, MD
miguelsanchez.hcsc@gmail.com+34913303223
Backup ContactAntonio S Núñez Reiz
anunezreiz@gmail.com+34913303223

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026